EpiCombi.AI Company
EpiCombi.AI is a genomics signature-driven therapeutics spinout from Oxford University, is overcoming epigenetic barriers in cancer complexity through the creation of AI-derived, network-acting multi-targeted drugs.
Headquarters:
Oxford,Oxfordshire,United Kingdom,Europe
Industry:
Cell & Gene Therapies
Founded Date:
2017-01-01
Funding Status:
private